Company
United StatesPublic company, NYSE: BMYBristol Myers Squibb Company (NYSE: BMY), Plainsboro, NJ – FDA Inspections
Inspection records and compliance data for Bristol Myers Squibb Company in Plainsboro, New Jersey. 2 FDA inspections on record, last inspected March 10, 2015. Publicly traded as NYSE: BMY.
Company Profile
This profile covers Bristol Myers Squibb Company based in Plainsboro, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected November 21, 2012. Last inspected March 10, 2015.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 10, 2015 | NAI | Human Drugs · Bioresearch Monitoring | 917301 |
| November 21, 2012 | NAI | Human Drugs · Bioresearch Monitoring | 806897 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bristol Myers Squibb Company
Stock ticker
BMY
Exchange
NYSE
Share price
$63.24
Market cap
$129.3B
Price as of
November 6, 2026
FEI Number
3004440557
Address
777 Scudders Mill Rd, Plainsboro, New Jersey 08536, United States
Country
United States
ID: 48118590-060e-40ac-9572-272fff700a66